참고문헌
- Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T. and Hurst, H. C. (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13, 1701-1707.
- Cheng, C., Ying, K., Xu, M., Zhao, W., Zhou, Z., Huang, Y., Wang, W., Xu, J., Zeng, L. and Xie, Y. and Mao, Y. (2002) Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1). Int. J. Biochem. Cell Biol. 34, 78-86. https://doi.org/10.1016/S1357-2725(01)00098-X
- Tummala, R., Romano, R. A., Fuchs, E. and Sinha, S. (2003) Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family. Gene 321, 93-102. https://doi.org/10.1016/S0378-1119(03)00840-0
- Hilger-Eversheim, K., Moser, M., Schorle, H. and Buettner, R. (2000) Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260, 1-12. https://doi.org/10.1016/S0378-1119(00)00454-6
- Feng, W. and Williams, T. (2003) Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb. Mol. Cell Neurosci. 24, 460-475. https://doi.org/10.1016/S1044-7431(03)00209-4
- Wang, H. V., Vaupel, K., Buettner, R., Bosserhoff, A. K. and Moser, M. (2004) Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev. Dyn. 231, 128-135. https://doi.org/10.1002/dvdy.20119
- Wu, F. and Lee, A. S. (2001) YY1 as a regulator of replication- dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J. Biol. Chem. 276, 28-34. https://doi.org/10.1074/jbc.M006074200
- Decary, S., Decesse, J. T., Ogryzko, V., Reed, J. C., Naguibneva, I., Harel-Bellan, A. and Cremisi, C. E. (2002) The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol. Cell Biol. 22, 7877-7888. https://doi.org/10.1128/MCB.22.22.7877-7888.2002
- Campillos, M., Garcia, M. A., Valdivieso, F. and Vazquez, J. (2003) Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic Acids Res. 31, 1571-1575. https://doi.org/10.1093/nar/gkg247
- Ding, X., Fan, C., Zhou, J., Zhong, Y., Liu, R., Ren, K., Hu, X., Luo, C., Xiao, S., Wang, Y., Feng, D. and Zhang, J. (2006) GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic Acids Res. 34, 2570-2578. https://doi.org/10.1093/nar/gkl319
- Garcia, M. A., Campillos, M., Marina, A., Valdivieso, F. and Vazquez, J. (1999) Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett. 444, 27-31. https://doi.org/10.1016/S0014-5793(99)00021-6
- Saksena, S., Dwivedi, A., Gill, R. K., Singla, A., Alrefai, W. A., Malakooti, J., Ramaswamy, K. and Dudeja, P. K. (2009) PKC-dependent stimulation of the human MCT1 promoter involves transcription factor AP2. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G275-283. https://doi.org/10.1152/ajpgi.90503.2008
- Imagawa, M., Chiu, R. and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51, 251-260. https://doi.org/10.1016/0092-8674(87)90152-8
- Iwamoto, N., Abe-Dohmae, S., Lu, R. and Yokoyama, S. (2008) Involvement of protein kinase D in phosphorylation and increase of DNA binding of activator protein 2 alpha to downregulate ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol. 28, 2282-2287. https://doi.org/10.1161/ATVBAHA.108.174714
- Gietz, R. D., Graham, K. C. and Litchfield, D. W. (1995) Interactions between the subunits of casein kinase II. J. Biol. Chem. 270, 13017-13021. https://doi.org/10.1074/jbc.270.22.13017
- Canton, D. A., Zhang, C. and Litchfield, D. W. (2001) Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta. Biochem. J. 358, 87-94. https://doi.org/10.1042/0264-6021:3580087
- Niefind, K., Guerra, B., Ermakowa, I. and Issinger, O. G. (2001) Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. Embo J. 20, 5320-5331. https://doi.org/10.1093/emboj/20.19.5320
- Romero-Oliva, F. and Allende, J. E. (2001) Protein p21(WAF1/CIP1) is phosphorylated by protein kinase CK2 in vitro and interacts with the amino terminal end of the CK2 beta subunit. J. Cell Biochem. 81, 445-452. https://doi.org/10.1002/1097-4644(20010601)81:3<445::AID-JCB1058>3.0.CO;2-2
- Lebrin, F., Chambaz, E. M. and Bianchini, L. (2001) A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha. Oncogene 20, 2010-2022. https://doi.org/10.1038/sj.onc.1204307
- Litchfield, D. W. (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15. https://doi.org/10.1042/BJ20021469
- Lin, J. M., Kilman, V. L., Keegan, K., Paddock, B., Emery-Le, M., Rosbash, M. and Allada, R. (2002) A role for casein kinase 2alpha in the Drosophila circadian clock. Nature 420, 816-820. https://doi.org/10.1038/nature01235
- Barz, T., Ackermann, K., Dubois, G., Eils, R. and Pyerin, W. (2003) Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling. J. Cell Sci. 116, 1563-1577. https://doi.org/10.1242/jcs.00352
- Gotz, C., Bachmann, C. and Montenarh, M. (2007) Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells. Prostate 67, 125-134. https://doi.org/10.1002/pros.20471
- Apopa, P. L., He, X. and Ma, Q. (2008) Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J. Biochem. Mol. Toxicol. 22, 63-76. https://doi.org/10.1002/jbt.20212
- Sarno, S., Moro, S., Meggio, F., Zagotto, G., Dal Ben, D., Ghisellini, P., Battistutta, R., Zanotti, G. and Pinna, L. A. (2002) Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol. Ther. 93, 159-168. https://doi.org/10.1016/S0163-7258(02)00185-7
- Sarno, S., Reddy, H., Meggio, F., Ruzzene, M., Davies, S. P., Donella-Deana, A., Shugar, D. and Pinna, L. A. (2001) Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase- 2'). FEBS Lett. 496, 44-48. https://doi.org/10.1016/S0014-5793(01)02404-8
- Batsche, E., Muchardt, C., Behrens, J., Hurst, H. C. and Cremisi, C. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell Biol. 18, 3647-3658. https://doi.org/10.1128/MCB.18.7.3647
- Williams, T. and Tjian, R. (1991) Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 251, 1067-1071. https://doi.org/10.1126/science.1998122
- Li, M., Wang, Y., Hung, M. C. and Kannan, P. (2006) Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int. J. Cancer 118, 802-811. https://doi.org/10.1002/ijc.21426
- Tapia, J. C., Torres, V. A., Rodriguez, D. A., Leyton, L. and Quest, A. F. (2006) Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/ lymphoid enhancer binding factor-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 103, 15079- 15084. https://doi.org/10.1073/pnas.0606845103
- Kim, Y. K., Lee, W. K., Jin, Y., Lee, K. J., Jeon, H. and Yu, Y. G. (2006) Doxorubicin binds to un-phosphorylated form of hNopp140 and reduces protein kinase CK2- dependent phosphorylation of hNopp140. J. Biochem. Mol. Biol. 39, 774-781. https://doi.org/10.5483/BMBRep.2006.39.6.774
- Guerra, B. and Issinger, O. G. (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20, 391-408. https://doi.org/10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N
- Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C. and Sonenshein, G. E. (2002) Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62, 6770-6778.
- Klapper, L. N., Kirschbaum, M. H., Sela, M. and Yarden, Y. (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77, 25-79.
- Pellikainen, J., Kataja, V., Ropponen, K., Kellokoski, J., Pietilainen, T., Bohm, J., Eskelinen, M. and Kosma, V. M. (2002) Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin. Cancer Res. 8, 3487-3495.
- Pellikainen, J. M. and Kosma, V. M. (2007) Activator protein- 2 in carcinogenesis with a special reference to breast cancer--a mini review. Int. J. Cancer 120, 2061-2067. https://doi.org/10.1002/ijc.22648
피인용 문헌
- The upstream stimulatory factor USF1 is regulated by protein kinase CK2 phosphorylation vol.26, pp.12, 2014, https://doi.org/10.1016/j.cellsig.2014.08.028
- RNF20 promotes the polyubiquitination and proteasome-dependent degradation of AP-2α protein vol.46, pp.2, 2014, https://doi.org/10.1093/abbs/gmt136